Skip to main content

Table 1 Characteristics of the 15 interviewees

From: HIV-related stigma and physical symptoms have a persistent influence on health-related quality of life in Australians with HIV infection

Patient

Age (yrs)

Gender m/f/o

Transmission mode

Year

CDC

CD4 (%)

Viral Load (log)

HAART*

Duration (mths)

1

48

m

msm

1985

C

35

<40

3TC/AZT/ABC

109

2

31

m

msm

2004

A

30

<40

3TC/AZT/EFV

42

3

41

f

unknown

1987

B

22

<40

FTC/TDF/LPV/RTV

180

4

66

m

hetero

1997

C

20

<40

3TC/DDI/RTV/ATV

114

5

28

f

hetero

1994

C

<6%

4.8

no current HAART

156

6

36

m

msm

2003

A

28

1.84

3TC/AZT/NVP

33

7

55

m

msm

1988

A

34

<40

3TC/ ABC/ LPV/RTV

78

8

47

m

msm

2002

A

26

<40

3TC/ ABC/ LPV/RTV

36

9

45

m

msm

2001

C

28

<40

3TC/TDF/NVP

72

10

38

m

msm

2006

A

17

<40

3TC/AZT/EFV

9

11

26

f

hetero

1998

A

49

<40

3TC/AZT/EFV

72

12

32

f

IDU

2001

A

32

3.92

no current HAART

72

13

44

m

msm

1986

C

21

2.16

3TC/AZT/ABC

156

14

37

m

msm

2005

A

30

<40

3TC/ABC/RTV/ATV

26

15

42

m

msm

2002

C

20

<40

3TC/AZT/EFV

63

  1. Abbreviations: msm = men who have sex with men, hetero= heterosexual, IDU = injecting drug use. HAART= highly active antiretroviral therapy; 3TC= lamivudine, FTC= emtricitabine, AZT= zidovudine, ABC = abacavir, TDF = tenofovir, DDI= didanosine, NVP= nevirapine, EFV= efavirenz, LPV=lopinavir, RTV= ritonavir, ATV= atazanavir; 8/13 patients on a BD regimen, mean number of pills = 3.4, median=3.
  2. CDC = stage at first presentation.